UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 14, 2023
Accession Number:
0001104659-23-115757
Submission Type:
POS AM
CIK:
0001270073
Company Name:
INTERCEPT PHARMACEUTICALS, INC.
File Number:
333-217861